We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 16 APRIL 2015
GSK-Novartis Transaction Approved In Canada Based On Commitments In EU And US
Affleck Greene McMurtry LLP
Although only the OTC joint venture was notifiable under Part IX of the Competition Act, the Bureau conducted a full analysis on all three parts of the proposed transaction.
GlobalAntitrust/Competition Law






